Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial

BACKGROUND: The aim of this phase II study was to evaluate combined nab-paclitaxel (nab-PTX) with sequential anthracycline-based therapy as a neoadjuvant chemotherapy. METHODS: We enrolled 41 patients with advanced breast cancer (stage IIA - IIIC). All patients were to receive three-weekly nab-PTX (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kin, Takanori, Ohtani, Shoichiro, Maeda, Reina, Ueno, Ayako, Fujihara, Miwa, Takamatsu, Yuri, Kajiwara, Yukiko, Ito, Mitsuya, Kawasaki, Kensuke, Abe, Keisuke, Sakata, Yasuhiko, Hiraki, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575276/
https://www.ncbi.nlm.nih.gov/pubmed/33117463
http://dx.doi.org/10.14740/wjon1333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575276/
https://www.ncbi.nlm.nih.gov/pubmed/33117463
http://dx.doi.org/10.14740/wjon1333

Ejemplares similares